Studies have shown that neoadjuvant nivolumab may provide long-term benefits for people with non-small cell lung cancer.

Published Date: 17 Feb 2023

BACKGROUND: NSCLC is the most common and important cause of cancer worldwide. Assessment: The patient...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Cancer cells with thick glycocalyx barrier evade immune system better: study

2.

Nanoparticle vaccine prevents multiple cancers and stops metastasis in mice

3.

A study has developed molecular markers that predict meningioma recurrence.

4.

Researchers identify a novel biomarker linked to renal cancer recurrence

5.

Pharyngoesophageal junction cancer is not a good candidate for endoscopically assisted transoral surgery.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot